Pathstone Holdings’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Pathstone Holdings's EXAS Position: Q1 2026 in Review
Pathstone Holdings sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 17,046 shares — an estimated $1.73M sold.
Pathstone Holdings first reported a position in EXAS in Q4 2023 and held it in 9 quarters. The position peaked at $1.73M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Pathstone Holdings reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Pathstone Holdings sold 17,046 Exact Sciences shares in Q1 2026, an estimated $1.73M.
- Pathstone Holdings first reported a position in Exact Sciences in Q4 2023 and held it in 9 quarters.
- Pathstone Holdings's Exact Sciences position peaked at $1.73M in Q4 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.